Deferred Registration: Quotient Sciences Code: QSC303709

Deferred registration: Quotient Sciences Code: QSC303709 [Full scientific title to be added on or before the deferral expiry date]

Registry ID

ISRCTN10081483

Source registry

ISRCTN

Status

Recruiting

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

Skyhawk Therapeutics, Inc.

Enrollment

8

Start date

2026-08-03

Completion date

2026-09-07

Last update

2026-08-17

Conditions

• Other

Summary

Healthy volunteers

Detailed description

This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Interventions

• DRUG: This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Inclusion criteria

This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Exclusion criteria

This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Locations

• , , United Kingdom
• , , England

Related clinical trials

• Helping young people to adapt their internet use and promote mental well-being in a rapidly changing world
• Testing a job crafting intervention to help make work more manageable, engaging and enjoyable for UK workers
• Understanding the impact of resistant bugs on deaths in England
• Helping local authorities to help parents: the BeST Engage Project
• Copen-SCALE: Scaling up an effective intervention to childcare institutions in Copenhagen
• Deferred registration: Quotient Sciences code: QSC303996

View on source registry